Abstract:Baculovirus has been widely used for the production of recombinant proteins in insect cells. The extremely high yield by baculovirus-infected insect cells or larvae makes it an attractive tool for pharmaceutical protein production. Since the finding that baculovirus can efficiently transduce mammalian cells, the applications of baculovirus have been greatly expanded. Although AcMNPV (Autographa californica multiple NPV) fails to replicate in vertebrate cells, it does express alien genes with levels of expression that are dependent on the strength of the promoter used to drive transcription of the foreign gene. Following these findings, subsequent studies have rapidly expanded the list of permissive cells that include cell lines originating from human, rodent, porcine, bovine and even fish sources. Many tries have been done to study the mechanism of baxulovirus entry into mammalian cells, but the events responsible for virus uptake and detailed mechanisms of intracellular movement and nuclear entry of the virus are still largely unknown. The application of modified baculoviruses for in vivo gene delivery has also been demonstrated. In contrast to other commonly used viral vectors, baculoviruses have the unique property of being incapable of initiating a replication cycle and producing infectious virus in mammalian cells. The AcMNPV genome is large, thus rendering the virus flexibility to carry multiple genes or large inserts. The recombinant viruses can be readily constructed and produced to high titers simply by infecting insect cells, initiate little to none microscopically observable cytopathic effects on mammalian cells and have a good biosafety profile. These attributes will undoubtedly lead to the increased application and continued development of this system for efficient gene delivery into mammalian cells.

Latest Developments in Highly Efficient Expression Vectors in Mammalian Cells

Advances on Highly Efficient Expression System of Mammalian Cells

Maximizing the Production of Recombinant Proteins in Plants: from Transcription to Protein Stability

[Effects of Gene Design on Recombinant Protein Expression: a Review].

Chromatin-modifying elements for recombinant protein production in mammalian cell systems

Progress of Transposon Vector System for Production of Recombinant Therapeutic Proteins in Mammalian Cells

Improvement strategies for transient gene expression in mammalian cells

Advances on the Expressions of Foreign Proteins in Plants

Expression vector cassette engineering for recombinant therapeutic production in mammalian cell systems

A novel application of baculovirus in mammalian gene therapy]

Recent Advances on the Expression Systems for Recombinant Protein Production

Improving Protein Quantity and Quality-The Next Level of Plant Molecular Farming

From Efficiency to Yield: Exploring Recent Advances in CHO Cell Line Development for Monoclonal Antibodies

Optimization of Protein Expression in Mammalian Cells

Optimization of a novel expression system for recombinant protein production in CHO cells

A New Optimization Strategy of Highly Branched Poly(β-Amino Ester) for Enhanced Gene Delivery: Removal of Small Molecular Weight Components.

Factors Affecting the Expression of Recombinant Protein and Improvement Strategies in Chinese Hamster Ovary Cells

Recent advances in expression and purification strategies for plant made vaccines

Efficient lentiviral transduction of different human and mouse cells

Increase recombinant antibody yields through optimizing vector design and production process in CHO cells

Recent advances in technology supporting biopharmaceutical production from mammalian cells